The present invention relates to isolated 18-mer peptides corresponding toamino acid residues 369-386 of human plasminogen activator inhibitor 1 (PAI-1)and fragments thereof, compositions comprising same, and uses thereof for treatingthromboembolic diseases and pathological conditions associated with neurologicaldamage.